Artigo de periodico

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells II: CAR-T cell therapy for patients with CD19+ acute lymphoblastic leukemia (2021)

• Authors:
  • Seber, Adriana
  • Castro Junior, Claudio Galvão de
  • Kerbauy, Lucila N.
  • Hirayama, Alexandre V.
  • Bonfim, Carmem
  • Fernandes, Juliana Folloni
  • Souza, Mair
  • Schafell, Rony
  • Nabhan, Samir
  • Loggetto, Sandra Regina
  • Simões, Belinda Pinto
  • Rocha, Vanderson Geraldo
  • Lima, Marcos de
  • Cunha, Renato Luiz Guerino
  • Bittencourt, Henrique
• USP affiliated authors: ROCHA, VANDERSON GERALDO - FM ; CUNHA, RENATO LUIZ GUERINO - FMRP
• Unidades: FM; FMRP
• DOI: 10.1016/j.htct.2021.09.002
• Subjects: CÉLULAS; LEUCEMIA; LINFOMA; SISTEMA IMUNE
• Keywords: Cellular therapy; Car-T cells; Immunotherapy; Adoptive cellular therapy; Advanced cellular therapy; Acute lymphoblastic leukemia; Acute lymphoid leukemia
• Language: Inglês
• Imprenta:
  • Publisher place: São José do Rio Preto
  • Date published: 2021
• Source:
  • Título: Hematology, Transfusion and Cell Therapy
  • ISSN: 2531-1379
  • Volume/Número/Paginação/Ano: v. 43, supl. 2, p.S13-S21, 2021

Informações sobre o DOI: 10.1016/j.htct.2021.09.002 (Fonte: oaDOI API)
• Este periódico é de acesso aberto
• Este artigo NÃO é de acesso aberto
  

---

Download do texto completo

Tipo	Nome	Link
	003232155.pdf	Direct link

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  SEBER, Adriana et al. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells II: CAR-T cell therapy for patients with CD19+ acute lymphoblastic leukemia. Hematology, Transfusion and Cell Therapy, v. 43, p. S13-S21, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2021.09.002. Acesso em: 10 fev. 2026.

• APA

  Seber, A., Castro Junior, C. G. de, Kerbauy, L. N., Hirayama, A. V., Bonfim, C., Fernandes, J. F., et al. (2021). Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells II: CAR-T cell therapy for patients with CD19+ acute lymphoblastic leukemia. Hematology, Transfusion and Cell Therapy, 43, S13-S21. doi:10.1016/j.htct.2021.09.002

• NLM

  Seber A, Castro Junior CG de, Kerbauy LN, Hirayama AV, Bonfim C, Fernandes JF, Souza M, Schafell R, Nabhan S, Loggetto SR, Simões BP, Rocha VG, Lima M de, Cunha RLG, Bittencourt H. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells II: CAR-T cell therapy for patients with CD19+ acute lymphoblastic leukemia [Internet]. Hematology, Transfusion and Cell Therapy. 2021 ; 43 S13-S21.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1016/j.htct.2021.09.002

• Vancouver

  Seber A, Castro Junior CG de, Kerbauy LN, Hirayama AV, Bonfim C, Fernandes JF, Souza M, Schafell R, Nabhan S, Loggetto SR, Simões BP, Rocha VG, Lima M de, Cunha RLG, Bittencourt H. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells II: CAR-T cell therapy for patients with CD19+ acute lymphoblastic leukemia [Internet]. Hematology, Transfusion and Cell Therapy. 2021 ; 43 S13-S21.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1016/j.htct.2021.09.002

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Umbilical Cord Blood Transplantation after Graft Failure from a Previous Hematopoietic Stem Cell Transplantation
• Umbilical cord blood transplantation after graft failure from a previous hematopoietic stem cell transplantation
• Associação prognóstica de polimorfismos gênicos da resposta imunológica em doadores e receptores de transplante não aparentado de células tronco hematopoiéticas de sangue de cordão umbilical e placentário
• The Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular seeks the implementation of, and access to, the CAR-T cell treatment in Brazil [Editorial]
• Haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for severe aplastic anemia
• Comparison of characteristics and laboratory tests of COVID-19 hematological patients from France and Brazil during the pre-vaccination period: identification of prognostic profiles for survival
• Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe
• Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases
• A novel mutation in RHAG causing Rh-null phenotype in Colombia. [Editorial]
• Comparative analysis of the variability of the human leukocyte antigen peptide-binding pockets in patients with acute leukaemia